FLT3 and acute myeloid leukemia: In most cases, the predominant AML clone is heterozygous for the FLT3-ITD mutation, although subclones may be biallelic, hemizygous, possess a different specific mutation, or lack the FLT3-ITD mutation altogether; such alterations also affect the AR [48,49].